0 results for 'Eli Lilly'
The $68 billion deal to acquire Wyeth isn't the only work Cadwalader is busy doing for Pfizer these days.
Counterfeit Drugs Create a Bitter Pill for Patients Overseas
In the United States, the most commonly counterfeited drugs are "lifestyle" medicines like Viagra, but in poor countries, it's the life-saving drugs that are fakes. Almost half of medicines in developing countries are counterfeit, according to the World Health Organization. Big Pharma doesn't like to talk about the issue, and authorities in poor countries don't have the resources to fight it. Even when they do, counterfeiters can always find a cheaper, less regulated place to go. Is a solution possible?Fake Drugs Create a Bitter Pill for Patients Overseas
In the United States, the most commonly counterfeited drugs are "lifestyle" medicines like Viagra, but in poor countries, it's the life-saving drugs that are fakes. Almost half of medicines in developing countries are counterfeit, according to the World Health Organization. Big Pharma doesn't like to talk about the issue, and authorities in poor countries don't have the resources to fight it. Even when they do, counterfeiters can always find a cheaper, less regulated place to go. Is a solution possible?After he lost the 2009 trial in Marshall, Tx., Bill Lee of Wilmer told us he was sure Abbott would be vindicated on appeal. He was right.
As Other IP Boutiques Falter, Finnegan Moves Forward
Finnegan, Henderson, Farabow, Garrett & Dunner stands as perhaps the healthiest IP boutique in the country -- at a time when other IP specialists have collapsed because of competitive pressure from general service firms, management woes and a turbulent economy. Finnegan's recipe for success includes high-end litigation, a deep bench of institutional clients, a clear succession plan and IP stars like partner Donald Dunner.Despite an apparent split between the Second and Ninth Circuits on the question of whether drug company sales reps are entitled to overtime, the Supreme Court decided to let stand an appellate ruling permitting a 2,700-plaintiff class action against Novartis to proceed to damages.
Merck became just the latest healthcare company to strike a major settlement with the Justice Department on Tuesday, agreeing to a $321.6 million criminal fine and a $628.3 million civil settlement to resolve claims over its marketing of the painkiller Vioxx.
Trending Stories
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now